Back to Screener

Healthcare

SpyGlass Pharma, Inc. Common Stock(SGP)

Live Price

Offline

$18.70

+2.75% today

Window Change

-31.10%

Window

Feb 6, 2026 โ†’ Jun 9, 2026

Market Cap
$760.00M
Revenue Growth
0.0%
EPS Growth
0.0%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 85 bars ยท Feb 6, 2026 โ†’ Jun 9, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

SpyGlass Pharma, Inc. Common Stock (SGP) is a Healthcare stock with a market cap of $760.00M and listed on NASDAQ. The stock last traded around $18.70 and down 31.1% across the available one-year price window (Feb 6, 2026 โ†’ Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines SGP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SGP

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SGP Max Drawdown

-38.71%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SGP and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

SpyGlass Pharma, Inc. Common Stock (SGP)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

Latest Revenue

โ€”

Latest Net Income

โ€”

Free Cash Flow

โ€”

Revenue Growth

+0.0%

EPS Growth

+0.0%

Gross Margin

0.0%

Net Margin

0.0%

No financial statement data available for SGP in annual view.

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.